Literature DB >> 16551896

A prospective evaluation of opioid weaning in opioid-dependent pediatric critical care patients.

Richard J Berens1, Michael T Meyer, Theresa A Mikhailov, Krista D Colpaert, Michelle L Czarnecki, Nancy S Ghanayem, George M Hoffman, Deborah J Soetenga, Thomas J Nelson, Steven J Weisman.   

Abstract

Critically ill children are treated with opioid medication in an attempt to decrease stress and alleviate pain during prolonged pediatric intensive care. This treatment plan places children at risk for opioid dependency. Once dependent, children need to be weaned or risk development of a withdrawal syndrome on abrupt cessation of medication. We enrolled opioid-dependent children into a prospective, randomized trial of 5- versus 10-day opioid weaning using oral methadone. Children exposed to opioids for an average of 3 wk showed no difference in the number of agitation events requiring opioid rescue (3 consecutive neonatal abstinence scores >8 every 2 h) in either wean group. Most of the events requiring rescue occurred on day 5 and 6 of the wean in both treatment groups. Patients may be able to be weaned successfully in 5 days once converted to oral methadone, with a follow-up period after medication wean to observe for a delayed withdrawal syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16551896     DOI: 10.1213/01.ane.0000202395.94542.3e

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  16 in total

1.  Use of methadone for prevention of opioid withdrawal in critically ill children.

Authors:  Sonia A Jeffries; Rumi McGloin; Alexander F Pitfield; Roxane R Carr
Journal:  Can J Hosp Pharm       Date:  2012-01

2.  Use of methadone for opioid weaning in children: prescribing practices and trends.

Authors:  Kazim Giby; Régis Vaillancourt; Nisha Varughese; Christina Vadeboncoeur; Annie Pouliot
Journal:  Can J Hosp Pharm       Date:  2014-03

3.  Effects of Clonidine on Withdrawal From Long-term Dexmedetomidine in the Pediatric Patient.

Authors:  Allison B Lardieri; Nicholas M Fusco; Shari Simone; L Kyle Walker; Jill A Morgan; Kristine A Parbuoni
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Jan-Feb

Review 4.  Methadone: applications in pediatric anesthesiology and critical care medicine.

Authors:  Joseph D Tobias
Journal:  J Anesth       Date:  2021-01-12       Impact factor: 2.078

5.  The Impact of a Clonidine Transition Protocol on Dexmedetomidine Withdrawal in Critically Ill Pediatric Patients.

Authors:  JiTong Liu; Jessica Miller; Michael Ferguson; Sandra Bagwell; Jonathan Bourque
Journal:  J Pediatr Pharmacol Ther       Date:  2020

6.  Impact of a Standardized Treatment Guideline for Pediatric Iatrogenic Opioid Dependence: A Quality Improvement Initiative.

Authors:  Rima Abdouni; Teri Reyburn-Orne; Tarek H Youssef; Imad Y Haddad; Richard D Gerkin
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Jan-Feb

7.  The Withdrawal Assessment Tool-1 (WAT-1): an assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediatric patients.

Authors:  Linda S Franck; Sion Kim Harris; Deborah J Soetenga; June K Amling; Martha A Q Curley
Journal:  Pediatr Crit Care Med       Date:  2008-11       Impact factor: 3.624

Review 8.  Defining sedation-related adverse events in the pediatric intensive care unit.

Authors:  Mary Jo C Grant; Michele C Balas; Martha A Q Curley
Journal:  Heart Lung       Date:  2013 May-Jun       Impact factor: 2.210

9.  Development and implementation of a pharmacist-managed, neonatal and pediatric, opioid-weaning protocol.

Authors:  Melissa R Johnson; David R Nash; Mary R Laird; Robert C Kiley; Michael A Martinez
Journal:  J Pediatr Pharmacol Ther       Date:  2014-07

Review 10.  Pharmacological treatment of chronic non-cancer pain in pediatric patients.

Authors:  Eapen Mathew; Eugene Kim; Kenneth R Goldschneider
Journal:  Paediatr Drugs       Date:  2014-12       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.